期刊文献+

雌孕激素联合补充治疗与脑卒中的预防 被引量:7

Estrogen-progestogen replacement therapy and prevention of stroke
下载PDF
导出
摘要 目的 探讨低剂量雌孕激素联合补充治疗对脑卒中的预防作用。方法 绝经过渡期及绝经后妇女84例随机设激素补充治疗组和对照组 ,采用酶免法测定治疗前后血脂和雌二醇 (E2 )水平。结果 治疗前后 E2、高密度脂蛋白 (HDL)增高 ,低密度脂蛋白 (L DL)、总胆固醇 (TC)降低 ,差异显著 (P<0 .0 5 ) ,甘油三酯 (TG)变化不明显。结论 低剂量雌激素对血脂谱产生有利影响 。 Objective To study the preventive role of stroke in lower dosage estrogen progestogen replacement therapy. Methods 84 cases in menopausal transition and postmenopausal periods were investigated and were assigned to 2 groups randomly,including hormone replacement therapy group and control group. The level of blood lipid and E2 were measured by enzyme linked immunosorbent assay. Results The level of E2 and HDL were higher,and the level of LDL and TC were lower. A significant difference was noted ( P <0.05). TG was no significant difference. Conclusion The lower dosage estrogen may produce beneficial effect on blood lipids and reduce the development of stroke.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2003年第1期22-23,共2页 Journal of Apoplexy and Nervous Diseases
关键词 雌孕激素 联合补充治疗 治疗 脑卒中 预防 Estrogen progestogen replacement therapy Stroke Blood lipid
  • 相关文献

参考文献3

二级参考文献11

  • 1[1]Grady D Gebretsadik J, Kerlikowske K, et al. Hormone replacement therapy and endometrial cancer risk: a mata-analysis[J]. Obstet Gynecol,1995,85(2):304-313.
  • 2[2]Woodruff JD, Pickar JH. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone[J]. Am J Obstet Gynecol,1994,170(5):1213-1223.
  • 3[3]The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women[J]. JAMA,1996,275(5):370-375.
  • 4[4]Weintein L, Bewtra C, Gallagher JC, et al. Evaluation of continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient[J]. Am J Obstet Gynecol,1990,162(6):1534-1542.
  • 5[5]Doren M, Reuther G, Minne HW, et al. Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women[J]. Am J Obstet Gynecol,1995,173(5):1446-1451.
  • 6[6]Archer DF, Pickar HJ, Bottiglioni F. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate[J]. Obstet Gynecol,1994,83(5):585-692.
  • 7[7]Clishan PR, deZiegler D, Lozano K, et al. Comparison of sequential versus continuous estrogen and progestin replacement therapy in postmenopausal women[J]. Obstet Gynecol,1991,77(2):241-246.
  • 8[8]Rauch U, Taubert HD. Continuous hormone replacement therapy with estradiol valerate and cholrmadinone acetate in adjustable doses. A preliminary study[J]. Maturates,1993,17(2):123-127.
  • 9[9]Dmark IS, Jonsson B, Backstr MT, et al. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone or with 17 β-estradiol and norethindrone acetate[J]. Am J Obstet Gynecol,2001,184(6):1131-1138.
  • 10[10]Sturdee DW, Ulrich LG, Barlow DH, et al. The endometrial response to sequential and continuous combined estrogen-progestogen replacement therapy[J]. Br J Obstet Gynecol,2000,107(11):1392-1400.

共引文献11

同被引文献64

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部